Comparative analysis of clinicopathologic features between adenoma and hyperplasia in surgically treated patients for hyperparathyroidism: A retrospective study

[1]  P. Bradley,et al.  The PROCESS 2020 Guideline: Updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) Guidelines. , 2020, International journal of surgery.

[2]  C. McHenry,et al.  Can parathyroid hyperplasia be predicted preoperatively? , 2017, American journal of surgery.

[3]  B. Guo,et al.  Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016 , 2018, Osteoporosis International.

[4]  I. Paunovíc,et al.  Surgical treatment of concomitant thyroid and parathyroid disorders: analysis of 4882 cases , 2017, European Archives of Oto-Rhino-Laryngology.

[5]  N. Robles,et al.  Prevalence of secondary hyperparathyroidism in patients with stage 3 and 4 chronic kidney disease seen in internal medicine , 2015 .

[6]  K. Duan,et al.  Clinicopathological correlates of hyperparathyroidism , 2015, Journal of Clinical Pathology.

[7]  Yan Jiang,et al.  Surgical diagnosis and treatment of primary hyperparathyroidism: analysis of 19 cases. , 2015, International journal of clinical and experimental medicine.

[8]  Mingxia Xiong,et al.  Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism , 2015, BMC Nephrology.

[9]  N. Robles,et al.  Prevalence of secondary hyperparathyroidism in patients with stage 3 and 4 chronic kidney disease seen in internal medicine , 2015 .

[10]  C. Timon,et al.  Co-existent thyroid disease in patients treated for primary hyperparathyroidism: implications for clinical management , 2015, European Archives of Oto-Rhino-Laryngology.

[11]  M. Barczyński,et al.  Reoperations for Persistent or Recurrent Primary Hyperparathyroidism: Results of a Retrospective Cohort Study at a Tertiary Referral Center , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[12]  Z. Baloch,et al.  Pathology of the parathyroid glands in hyperparathyroidism. , 2013, Seminars in diagnostic pathology.

[13]  R. DeLellis,et al.  Parathyroid tumors and related disorders , 2011, Modern Pathology.

[14]  Herb Chen,et al.  Operative Failures After Parathyroidectomy for Hyperparathyroidism: The Influence of Surgical Volume , 2010, Annals of surgery.

[15]  J. Wieneke,et al.  Parathyroid Adenoma , 2008, Head and neck pathology.

[16]  Q. Duh,et al.  Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. , 2006, Archives of surgery.

[17]  J. Kuhn,et al.  Comparison of quick parathyroid assay for uniglandular and multiglandular parathyroid disease. , 2002, American journal of surgery.

[18]  P. Aló,et al.  P53 as a marker of differentiation between hyperplastic and adenomatous parathyroids. , 2002, Annals of diagnostic pathology.

[19]  D. Farley,et al.  The predictive value of laboratory findings in patients with primary hyperparathyroidism. , 2002, Journal of the American College of Surgeons.

[20]  A. Gamboa-Domínguez,et al.  Histologic diagnosis of primary hyperparathyroidism: A concordance analysis between three pathologists , 2001, Endocrine pathology.

[21]  T. Tsuzuki,et al.  Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma. , 1999, Kidney international.

[22]  J. Rastad,et al.  Histological and clinical features of non-familial primary parathyroid hyperplasia. , 1992, Pathology, research and practice.

[23]  O. Ljungberg,et al.  Peroperative fat staining of frozen sections in primary hyperparathyroidism. , 1979, The American journal of pathology.